The agreement between the two companies also provides an opportunity for Global Stem Cells Group to expand the network by training additional physicians in Bioheart's regenerative medicine techniques while contributing to the development and commercialization of Bioheart's regenerative medicine products.
"Combining the large network of physicians at Global Stem Cells Group with currently available Bioheart therapies and products will help strengthen and broaden our program. We are looking forward to working with GSCG to expand our therapies globally and offer new therapies to patients who suffer from debilitating conditions." said Mike Tomas, CEO of Bioheart, Inc.
Global Stem Cells Group, a biotech company specializing in adult stem cell research, therapies and products, is comprised of six cutting-edge stem cell treatment companies each with a distinct mission based on research and proven technology.
The Global Stem Cells Group offers a sophisticated global network of physicians to train other physicians in these innovative cellular therapies and techniques, and to provide them to patients from all corners of the world.
"We're very pleased to be working with Bioheart to expand their therapies globally. Our companies are both focused on delivering cellular therapies to patients everywhere who suffer from debilitating medical conditions and disease, and that makes this collaboration a natural one." said Global Stem Cells Group Founder and COO Ricardo de Cubas.